Tan et al., 2013 - Google Patents
Ultradepletion of human plasma using chicken antibodies: a proof of concept studyTan et al., 2013
- Document ID
- 12076934492994003820
- Author
- Tan S
- Mohamedali A
- Kapur A
- Baker M
- Publication year
- Publication venue
- Journal of proteome research
External Links
Snippet
Human plasma arguably represents the most comprehensive version of the human proteome. Despite its immense theoretical discovery potential, plasma has many high and medium abundance proteins that mask low abundance protein disease biomarkers of …
- 210000002381 Plasma 0 title abstract description 350
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
- G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
- G01N33/6803—General methods of protein analysis not limited to specific proteins or families of proteins
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
- G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
- G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N27/00—Investigating or analysing materials by the use of electric, electro-chemical, or magnetic means
- G01N27/26—Investigating or analysing materials by the use of electric, electro-chemical, or magnetic means by investigating electrochemical variables; by using electrolysis or electrophoresis
- G01N27/416—Systems
- G01N27/447—Systems using electrophoresis
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N30/00—Investigating or analysing materials by separation into components using adsorption, absorption or similar phenomena or using ion-exchange, e.g. chromatography or field flow fractionation
- G01N30/02—Column chromatography
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
- C07K1/14—Extraction; Separation; Purification
- C07K1/16—Extraction; Separation; Purification by chromatography
- C07K1/22—Affinity chromatography or related techniques based upon selective absorption processes
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2800/00—Detection or diagnosis of diseases
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Tan et al. | Ultradepletion of human plasma using chicken antibodies: a proof of concept study | |
Reid et al. | MetaUniDec: high-throughput deconvolution of native mass spectra | |
Gong et al. | Different immunoaffinity fractionation strategies to characterize the human plasma proteome | |
Tu et al. | Depletion of abundant plasma proteins and limitations of plasma proteomics | |
Levy et al. | Identification and characterization of host cell protein product‐associated impurities in monoclonal antibody bioprocessing | |
Macron et al. | Deep dive on the proteome of human cerebrospinal fluid: a valuable data resource for biomarker discovery and missing protein identification | |
Thongboonkerd | Practical points in urinary proteomics | |
Thongboonkerd et al. | Systematic evaluation of sample preparation methods for gel-based human urinary proteomics: quantity, quality, and variability | |
Castagna et al. | Exploring the hidden human urinary proteome via ligand library beads | |
Kreunin et al. | Bladder cancer associated glycoprotein signatures revealed by urinary proteomic profiling | |
Al-Daghri et al. | Whole serum 3D LC-nESI-FTMS quantitative proteomics reveals sexual dimorphism in the milieu interieur of overweight and obese adults | |
Yocum et al. | Effect of immunoaffinity depletion of human serum during proteomic investigations | |
Yu et al. | Improved titanium dioxide enrichment of phosphopeptides from HeLa cells and high confident phosphopeptide identification by cross-validation of MS/MS and MS/MS/MS spectra | |
Faca et al. | Quantitative analysis of acrylamide labeled serum proteins by LC− MS/MS | |
Kawashima et al. | High-yield peptide-extraction method for the discovery of subnanomolar biomarkers from small serum samples | |
Cao et al. | Integration of a two-phase partition method into proteomics research on rat liver plasma membrane proteins | |
Jin et al. | Human plasma proteome analysis by multidimensional chromatography prefractionation and linear ion trap mass spectrometry identification | |
Chen et al. | Improved host cell protein analysis in monoclonal antibody products through molecular weight cutoff enrichment | |
Zhu et al. | Comprehensive mapping of protein N-glycosylation in human liver by combining hydrophilic interaction chromatography and hydrazide chemistry | |
Ohlmeier et al. | Sputum proteomics identifies elevated PIGR levels in smokers and mild-to-moderate COPD | |
Patel et al. | Assessment of two immunodepletion methods: off-target effects and variations in immunodepletion efficiency may confound plasma proteomics | |
Song et al. | Proteomic analysis of breast cancer tissues to identify biomarker candidates by gel-assisted digestion and label-free quantification methods using LC-MS/MS | |
Garbis et al. | A Novel multidimensional protein identification technology approach combining protein size exclusion prefractionation, peptide zwitterion− ion hydrophilic interaction chromatography, and nano-ultraperformance RP chromatography/nESI-MS2 for the in-depth analysis of the serum proteome and phosphoproteome: Application to clinical sera derived from humans with benign prostate hyperplasia | |
Todoroki et al. | Current mass spectrometric tools for the bioanalyses of therapeutic monoclonal antibodies and antibody-drug conjugates | |
Liang et al. | Bridged hybrid monolithic column coupled to high-resolution mass spectrometry for top-down proteomics |